Patents

Junker A. Purine and Pyrimidine Nucleotides as Ecto-5’-Nucleotidase Inhibitors. U.S. Patent Application No. 62/719,492 filed August 17, 2018. HHS E-132-2018-0-US-01.

Junker A. Triazole derivatives as P2Y14 receptor antagonists. U.S. Patent application No. US 62/233,162 filed September 25, 2015; filed as PCT on September 26, 2016 HHS E-213-2015/0-PCT-02; Issued on March 30th 2017, WO/2017/053769.

Faust A, Hermann S, Roth J, Schäfers M, Vogl T. Quinolone-3-carboxamide compounds and their use in diagnosis. WO 2016067238 A1; publication date: 06/05/2016. PCT/IB2015/058348; publication date: 06/05/2016.

Hayes C, Ladebeck R, Schäfers K. Method for motion correction of emission computed tomography data by way of magnetic resonance tomography data. US-20140357980; publication date: 04/12/2014.

Chen G, Gangadharmath UB, Kasi D, Kolb HC, Liu C, Sinha A, Szardenings AK, Walsh JC, Wang E, Yu C, Zhang W, Kopka K, Haufe G, Schäfers M, Hugenberg V, Wagner S, Hermann S, Breyholz H-J, Faust A. Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof. EP 2644601; 02/10/2013.

Haufe G, Schilson S, Keul P, Levkau B, Schäfers M. New ligands for targeting of S1P receptors for in vivo imaging and treatment of diseases. EP 2559683; 20/02/2013. WO 2013/026765; 28/02/2013. EP 2744776; 25/06/2014.

Haufe G, Hermann S, Hugenberg V, Kolb H, Kopka K, Wagner S, Schäfers M. Compounds with matrix-metalloproteinase inhibitory activity. WO 2013/010573; publication date: 24/01/2013.

Behrends M, Breyholz H-J, Hermann S, Haufe G, Hugenberg V, Kolb H, Kopka K, Wagner S, Schäfers M. Compounds with matrix-metalloproteinase inhibitory activity. EP 2520573; publication date: 07/11/2012.

Bremer C, Höltke C, Kopka K, Schäfers M. A fluorescent photoprobe for the imaging of endothelin receptors. WO 2007/028599; 15/03/2007. EP 1931392; 18/06/2008.

Kopka K, Levkau B, Schäfers M. 5-Pyrrolidinylsulfonyl isatin derivatives. WO 2006/074799; 20/07/2006. EP 1841759; 10/10/2007.